Explore all your clinically proven options in one place.
The following information is provided to support understanding of prescription options that may be considered following medical assessment.
Mounjaro (Tirzepatide) Injection
A prescription is not guaranteed. If, following your consultation, your prescriber determines that treatment is not suitable, a prescription will not be issued.
*Clinical outcomes vary between individuals.
Wegovy (Semaglutide) Injection
A prescription is not guaranteed. If, following your consultation, your prescriber determines that treatment is not suitable, a prescription will not be issued.
*Clinical outcomes vary between individuals.
Active ingredient
Engages both GLP-1 and GIP receptors to regulate appetite, improve satiety, and support blood sugar control. This dual mechanism may support greater weight loss compared to single-pathway treatments.
How it works
Acts on GLP-1 and GIP receptors to help regulate appetite, increase satiety, and improve insulin sensitivity. This dual mechanism may result in greater weight loss compared to GLP-1 alone
Typical weight loss
Up to 22% of body weight¹
How to take
Frequency
Once a week
Dosing
Active ingredient
How it works
Targets the GLP-1 receptor to slow gastric emptying and reduce appetite, helping to lower calorie intake and improve glycaemic control.
Typical weight loss
Up to 15% of body weight¹
How to take
Frequency
Once a week
Dosing
¹ Mounjaro and Wegovy are licensed in Ireland for weight management. Results may vary.
At WeightLossInjections.ie, we support weight management through doctor-led medical consultations. In appropriate clinical circumstances, prescribers may consider prescription treatments used in weight management, including injectable treatments that act on GLP-1 pathways, as well as treatments that act on both GLP-1 and GIP pathways.
Not all treatments are suitable for everyone. Every consultation is carefully reviewed by a licensed prescriber, and if a GLP-1- or GLP-1/GIP-based treatment is not considered clinically appropriate, it will not be prescribed. Patient safety is always the priority, and prescribers will guide patients toward the most appropriate option based on individual medical assessment.
Prescription treatments used in weight management are typically administered on a regular schedule, as determined by your prescriber.
Your doctor will provide guidance specific to your treatment plan, including how and when it should be used. If you have any questions about your schedule, your prescriber or pharmacist will be able to advise you.
We provide online medical consultations. If you are eligible, your prescriber may issue a prescription following your consultation.
Where a prescription is issued, it is sent to a licensed pharmacy for dispensing. The pharmacy will then advise on collection or delivery options, subject to their own services.
Ongoing medical oversight is an important part of treatment. Follow-up consultations are required to review progress and ensure continued suitability before any further prescriptions are considered.
These follow-up consultations are typically faster, as your information is securely stored and you can log back in.
We can answer your questions about medical weight management.
Disclaimer: Wegovy® and Mounjaro® are registered trademarks of their respective manufacturers. This website is not affiliated with, endorsed by, or sponsored by Novo Nordisk (Wegovy®) or Eli Lilly and Company (Mounjaro®). All trademarks are the property of their respective owners.
Disclaimer: Wegovy® and Mounjaro® are registered trademarks of their respective manufacturers. This website is not affiliated with, endorsed by, or sponsored by Novo Nordisk (Wegovy®) or Eli Lilly and Company (Mounjaro®). All trademarks are the property of their respective owners.
